Iron deficiency in chronic heart failure: An international pooled analysis

American Heart Journal

Volumn 165, Issue 4, 2013, Pages

  Klip, Ijsbrand T ^a   Comin Colet, Josep ^b   Voors, Adriaan A ^a   Ponikowski, Piotr ^c   Enjuanes, Cristina ^b   Banasiak, Waldemar ^c   Lok, Dirk J ^d   Rosentryt, Piotr ^e   Torrens, Ainhoa ^b   Polonski, Lech ^e   Van Veldhuisen, Dirk J ^e   Van Der Meer, Peter ^a   Jankowska, Ewa A ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d DEVENTER HOSPITAL   (Netherlands)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; FERRITIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSFERRIN BLOOD LEVEL;

EID: 84875474830     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.01.017     Document Type: Article

References (43)

1. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
2. H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients: a systematic review and meta-analysis J Am Col Cardiol 52 2008 818 827
3. J.K. Ghali Anemia and heart failure Curr Opin Cardiol 24 2009 172 178
4. D.S. Silverberg, D. Wexler, and A. Iaina The role of anemia in patients with congestive heart failure: a short review Eur J Heart Fail 10 2008 819 823
5. S. Von Haehling, D.J. van Veldhuisen, and M. Roughton Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study Eur J Heart Fail 13 2011 656 663
6. P. Van der Meer, and D.J. van Veldhuisen Anaemia and renal dysfunction in chronic heart failure Heart 95 2009 1808 1812
7. B.D. Westenbrink, F.W. Visser, and A.A. Voors Anemia in chronic heart failure is not only related to impaired renal function and blunted erythropoietin production, but to fluid retention as well Eur Heart J 28 2007 166 171
8. D.J. Van Veldhuisen, S.D. Anker, and P. Ponikowski Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches Nat Rev Cardiol 8 2011 485 493
9. P. Van der Meer, E. Lipsic, and B.D. Westenbrink Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure Circulation 112 2005 1743 1747
10. Fairbanks V, Beutler E. Iron deficiency. In Beutler E, editor. Williams Hematology. 6th ed. New York: McGraw-Hill 2001:295-304 and 447-50.
11. J.L. Beard Iron biology in immune function, muscle metabolism and neuronal functioning J Nutr 131 Suppl. 2 2001 568 579
12. E.A. Jankowska, P. Rozentryt, and A. Witkowska Iron deficiency: an ominous sign in patients with systolic chronic heart failure Eur Heart J 15 2010 1872 1880
13. A. Besarab, W.A. Horl, and D. Silverberg Iron metabolism, iron deficiency, thrombocytosis and the cardiorenal anemia syndrome Oncologist 14 2009 22 33
14. J.D. Haas, and T. Brownlie Iron deficiency and reduced work capacity: a critical review to determine a causal relationship J Nutr 131 Suppl. 2 2001 676S 688S
15. E.A. Jankowska, P. Rosentryt, and A. Witkowska Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure J Card Fail 17 2011 899 906
16. A.P. Bolger, F.R. Bertlett, and H.S. Penston Intravenous iron alone for the treatment of anemia in patients with chronic heart failure J Am Coll Cardiol 48 2006 1225 1227
17. J.E. Toblli, A. Lombrana, and P. Duarte Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure end renal insufficiency J Am Coll Cardiol 50 2007 1657 1665
18. D.O. Okonko, A. Grzeslo, and T. Witkowski Effects of intravenous iron sucrose on exercise tolerance in anemic and non-anemic patients with symptomatic heart failure and iron deficiency; FERRIC-HF: a randomized, controlled, observer-blinded trial J Am Coll Cardiol 51 2008 103 112
19. R.I. Usmanov, E.B. Zueva, and D.S. Silverberg Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure J Nephrol 21 2008 236 242
20. S.D. Anker, J. Comin-Colet, and G. Filippatos Ferric carboxymaltose in patients with heart failure and iron deficiency N Eng J Med 361 2009 2436 2448
21. J. Comin-Colet, M. Lainscak, and K. Dickstein The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study Eur Heart J 2012 Jan 31 10.1093/eurheartj/ehr504 [E-pub ahead of print]
22. D.O. Okonko, A.K.J. Mandal, and C.G. Missouris Disordered iron homeostatis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival J Am Coll Cardiol 58 2011 1241 1251
23. A. Parikh, S. Natarajan, and S.R. Lipsitz Iron deficiency in community-dwelling U.S. adults with self-reported heart failure in NHANES III: prevalence and association with anemia and inflammation Circ Heart Fail 4 2011 599 606
24. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
25. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 9386 2003 777 781
26. C. Enjuanes-Grau, J. Comin-Colet, and A. Torrens-Oses Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless the anaemia status Eur J Heart Fail Suppl 11 2012 S146
27. P.W. Bruggink-André de la Porte, D.J. Lok, and J. van Wijngaarden Heart failure programs in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study Eur J Heart Fail 7 2005 910 920
28. S. Willemsen, J.W. Hartog, and Y. Hummel Effects of alagebrium, an advanced glycation endproduct breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial Eur J Heart Fail 12 2010 294 300
29. WHO Scientific Group Nutritional anaemias. Report of a WHO scientific group World Health Organ Tech Rep Ser 405 1968 5 37
30. J. Beilby, J. Olynyk, and S. Ching Transferrin index: an alternative method for calculating the iron saturation of transferrin Clin Chem 38 1992 2078 2081
31. M.J. Pencina, R.B. D'Agostino Sr., and R.B. D'Agostino Jr. Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
32. Alexandrakis MG, Tsirakis G. Anemia in heart failure patients. ISRN Hematol 2012;epub ahead of print.
33. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Eng J Med 352 2005 1011 1023
34. G. Weiss Iron metabolism in the anemia of chronic disease Biochim Biophys Acta 1790 2009 682 693
35. J. Balla, V. Jeney, and Z. Varga Iron homeastasis in chronic inflammation Acta Physiol Hung 94 2007 95 106
36. C. Opasich, M. Cazzola, and L. Scelsi Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes for anaemia in patients with heart failure Eur Heart J 26 2005 2232 2237
37. J.N. Nanas, C. Matsouka, and D. Karageorgopoulos Etiology of anemia in patients with advanced heart failure J Am Coll Cardiol 48 2006 2485 2489
38. J.D. Cook, C.A. Finch, and N.J. Smith Evaluation of the iron status of a population Blood 48 1976 449 455
39. A. Looker, P. Dallman, and M. Carroll Prevalence of iron deficiency in the United States JAMA 277 1997 973 976
40. L. Kleijn, A.M. Belonje, and R.A. de Boer Inflammation and anaemia in a broad spectrum of patients with heart failure Heart 98 2012 1237 1241
41. K. Kalantar-Zadeh, and Gh. Lee The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol 1 2006 S9 S18
42. J.B. Wish Assessing iron status: beyond ferritin and transferrin saturation Clin J Am Soc Nephrol 1 2006 S4 S8
43. J.M. Kim, C.H. Ihm, and H.J. Kim Evalutation of reticulocyte haemoglobin content as a marker of iron deficiency and predictor of response intravenous iron in haemodialysis patients Int J Lab Hematol 30 2008 46 52